Publication | Closed Access

Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology

Hematological MalignancyOncologyLeukemia Working GroupHematologyClinical TrialsPharmacologyMyeloid NeoplasiaPharmacotherapyHellenic SocietyMedicineHealth Sciences